FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892895380> ?p ?o ?g. }

• W2892895380 endingPage "177" @default.
• W2892895380 startingPage "166" @default.
• W2892895380 abstract "A series of 3-N-aryl substituted-2-heteroarylchromones was efficiently synthesized via Pd-mediated oxidative coupling under the influence of hetero-atoms neighboring group participation. Synthesized molecules were evaluated against human microtubule affinity regulating kinase 4 (MARK4) enzyme inhibitors, a recently identified anti-cancer drug target. Among 21 synthesized molecules, compounds 2, 3, and 14 exhibited excellent in vitro inhibitory effect against MARK4 with IC50 value (50% of ATPase activity) at 2.12 ± 0.22 μM, 1.98 ± 0.34 μM and 5.56 ± 0.42 μM respectively. The fluorescence binding and dot blot assay of these compounds were found in μM range, indicating a better binding affinity. In vitro study of these compounds against cancerous cells (MCF-7 and HepG2) inhibited the cell viability, induced apoptosis and lowered the tau-phosphorylation. Cell viability studies of compounds 2, 3, and 14 showed inhibition of cancerous cells growth with IC50 values of 3.22 ± 0.42, 4.32 ± 0.23 μM and 16.22 ± 1.33 μM for human breast cancer cells (MCF-7) and 6.45 ± 1.12, 5.22 ± 0.72 μM and 19.12 ± 1.43 μM for human liver carcinoma cells (HepG2) respectively. ROS quantification of these compounds showed oxidative stress to cancerous cells and molecular docking study showed hydrogen bonding, charge or polar and van der Waals interactions with the active site residues of MARK4. Owning to high binding fit nicely in the active site, offering the possibilities to be used as novel therapeutic molecules in the drug discovery against MARK4-related diseases." @default.
• W2892895380 created "2018-10-05" @default.
• W2892895380 creator A5005222796 @default.
• W2892895380 creator A5021941753 @default.
• W2892895380 creator A5036712828 @default.
• W2892895380 creator A5078036000 @default.
• W2892895380 creator A5081888893 @default.
• W2892895380 date "2018-11-01" @default.
• W2892895380 modified "2023-09-29" @default.
• W2892895380 title "Synthesis, molecular docking and inhibition studies of novel 3-N-aryl substituted-2-heteroarylchromones targeting microtubule affinity regulating kinase 4 inhibitors" @default.
• W2892895380 cites W1971627685 @default.
• W2892895380 cites W1977178308 @default.
• W2892895380 cites W2000296647 @default.
• W2892895380 cites W2001443225 @default.
• W2892895380 cites W2027013034 @default.
• W2892895380 cites W2028069947 @default.
• W2892895380 cites W2030962147 @default.
• W2892895380 cites W2036542494 @default.
• W2892895380 cites W2041166620 @default.
• W2892895380 cites W2046413689 @default.
• W2892895380 cites W2051266786 @default.
• W2892895380 cites W2053260150 @default.
• W2892895380 cites W2067978364 @default.
• W2892895380 cites W2081514970 @default.
• W2892895380 cites W2086788854 @default.
• W2892895380 cites W2093218372 @default.
• W2892895380 cites W2105668062 @default.
• W2892895380 cites W2117692326 @default.
• W2892895380 cites W2140012510 @default.
• W2892895380 cites W2143498800 @default.
• W2892895380 cites W2148286490 @default.
• W2892895380 cites W2151118352 @default.
• W2892895380 cites W2151864089 @default.
• W2892895380 cites W2221837786 @default.
• W2892895380 cites W2255131494 @default.
• W2892895380 cites W2313842368 @default.
• W2892895380 cites W2322377288 @default.
• W2892895380 cites W2324150675 @default.
• W2892895380 cites W2328935951 @default.
• W2892895380 cites W2330631897 @default.
• W2892895380 cites W2349856532 @default.
• W2892895380 cites W2388596458 @default.
• W2892895380 cites W2410793979 @default.
• W2892895380 cites W2463634719 @default.
• W2892895380 cites W2587094719 @default.
• W2892895380 cites W2738784229 @default.
• W2892895380 cites W2746410660 @default.
• W2892895380 cites W2748267704 @default.
• W2892895380 cites W2766064695 @default.
• W2892895380 cites W2917837889 @default.
• W2892895380 cites W2949065571 @default.
• W2892895380 cites W2950359446 @default.
• W2892895380 doi "https://doi.org/10.1016/j.ejmech.2018.09.030" @default.
• W2892895380 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30290280" @default.
• W2892895380 hasPublicationYear "2018" @default.
• W2892895380 type Work @default.
• W2892895380 sameAs 2892895380 @default.
• W2892895380 citedByCount "37" @default.
• W2892895380 countsByYear W28928953802019 @default.
• W2892895380 countsByYear W28928953802020 @default.
• W2892895380 countsByYear W28928953802021 @default.
• W2892895380 countsByYear W28928953802022 @default.
• W2892895380 countsByYear W28928953802023 @default.
• W2892895380 crossrefType "journal-article" @default.
• W2892895380 hasAuthorship W2892895380A5005222796 @default.
• W2892895380 hasAuthorship W2892895380A5021941753 @default.
• W2892895380 hasAuthorship W2892895380A5036712828 @default.
• W2892895380 hasAuthorship W2892895380A5078036000 @default.
• W2892895380 hasAuthorship W2892895380A5081888893 @default.
• W2892895380 hasConcept C121608353 @default.
• W2892895380 hasConcept C159110408 @default.
• W2892895380 hasConcept C161624437 @default.
• W2892895380 hasConcept C181199279 @default.
• W2892895380 hasConcept C184235292 @default.
• W2892895380 hasConcept C185592680 @default.
• W2892895380 hasConcept C190283241 @default.
• W2892895380 hasConcept C202751555 @default.
• W2892895380 hasConcept C2777752497 @default.
• W2892895380 hasConcept C41685203 @default.
• W2892895380 hasConcept C53227056 @default.
• W2892895380 hasConcept C54355233 @default.
• W2892895380 hasConcept C55493867 @default.
• W2892895380 hasConcept C71240020 @default.
• W2892895380 hasConcept C71924100 @default.
• W2892895380 hasConcept C86803240 @default.
• W2892895380 hasConcept C96232424 @default.
• W2892895380 hasConceptScore W2892895380C121608353 @default.
• W2892895380 hasConceptScore W2892895380C159110408 @default.
• W2892895380 hasConceptScore W2892895380C161624437 @default.
• W2892895380 hasConceptScore W2892895380C181199279 @default.
• W2892895380 hasConceptScore W2892895380C184235292 @default.
• W2892895380 hasConceptScore W2892895380C185592680 @default.
• W2892895380 hasConceptScore W2892895380C190283241 @default.
• W2892895380 hasConceptScore W2892895380C202751555 @default.
• W2892895380 hasConceptScore W2892895380C2777752497 @default.
• W2892895380 hasConceptScore W2892895380C41685203 @default.
• W2892895380 hasConceptScore W2892895380C53227056 @default.
• W2892895380 hasConceptScore W2892895380C54355233 @default.

• next